cefotaxime sodium
Drug ingredientActive ShortageThis drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.
Where It Comes From
3 FDA-registered drug labelers
ACS Dobfar S.p.A
Hikma Pharmaceuticals USA Inc.
SteriMax Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Cefotaxime
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
Active Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
current
Cefotaxime Sodium Powder, for Solution
02/17/2015Unavailable
current
Cefotaxime Sodium Powder, for Solution
02/17/2015Available
Chemical Identity
CAS64485-93-4
PubChem CID10695961
DTXSIDDTXSID4046991
FormulaC16H16N5NaO7S2
Mol. Weight477.5 g/mol
SMILESCC(=O)OCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)[O-].[Na+]
Data Sources
106959612026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/cefotaxime sodium/cids/JSON
Archive: data/sources/pubchem_name/cefotaxime sodium.json
CAS 64485-93-42026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 64485-93-42026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json